More stories
Mitchell
News Release
Symbicort Generic Approval on March 15, 2022
Recently the U.S. Food and Drug Administration (FDA) approved a generic formulation of Symbicort metered-dose inhaler for the treatment of asthma or chronic obstructive pulmonary disease (COPD).
Workers' Comp
Article
High Dollar Claims Driving Workers’ Compensation COVID-19 Claims Costs
Data analysis by Aarthi Thiruvengadam.
Disability
Article
Ticket to Work
We all have bad days at work when we dream about how nice it would be to not have to earn a paycheck. But how long would we be happy?
Mitchell
Conference
HD Repair Forum
The HD Repair Forum is dedicated to serving those involved in the collision repair work of
Workers' Comp
Article
The Rise of Fentanyl in the Midst of an Already Troubling Opioid Epidemic
Each day we hear more and more stories of addiction, overdose, and deaths with heartbreaking stories of the individuals and the families who have been impacted by the opioid epidemic.
The Fintech Times
Article
Insurtech Innovations in Tech with EvolutionIQ, CoTé, Genex Services, Kinetic Insurance
Shahin Hatamian, senior vice president of product management at Mitchell, believes the use of data and analytics have seen major innovation in the